Please enter a valid ZIP code

What do you look for most in your
on-demand bleed treatment?


NovoSeven® RT means:

Since 1999, NovoSeven® RT has been providing you with what
you expect from bleed treatments — even during surgery

  • Experience: 30 years of research and long-term clinical experiencea
  • Portability: Room temperature stable for fast access to treatment
  • Speed: Fast mixing and infusion time leading to fast activity
  • Effectiveness: Proven effective in 4 indications plus surgery
    —more than any other factor product
  • Safety: Low rate of thrombotic adverse eventsb
  •     aCompassionate use, also known as expanded access, began enrolling in 1988; FDA approval received in 1999.
        bIn people with hemophilia A or B with inhibitors.





Indications and Usage

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for:

Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Warnings and Precautions

Side Effects

Use with Other Drugs

Please click here for NovoSeven® RT Prescribing Information and Instructions For Use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch,
or call 1-800-FDA-1088.

NovoSeven® RT is a prescription medicine. Novo Nordisk provides patient assistance for those who qualify. Please call 1-877-NOVO-777 (1-877-668-6777) to learn more about Novo Nordisk assistance programs.